Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Retained Earnings: 2024

Historic Retained Earnings for Pyxis Oncology (PYXS) over the last 1 years, with Dec 2024 value amounting to -$363.6 million.

  • Pyxis Oncology's Retained Earnings fell 29.60% to -$425.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$425.1 million, marking a year-over-year decrease of 29.60%. This contributed to the annual value of -$363.6 million for FY2024, which is N/A change from last year.
  • As of FY2024, Pyxis Oncology's Retained Earnings stood at -$363.6 million.
  • Pyxis Oncology's 5-year Retained Earnings high stood at -$363.6 million for FY2024, and its period low was -$363.6 million during FY2024.
  • Over the past 1 years, Pyxis Oncology's median Retained Earnings value was -$363.6 million (recorded in 2024), while the average stood at -$363.6 million.